An Old Drug Learning New Tricks: A REPRIEVE for Cardiovascular Disease in HIV Infection

Clin Chem. 2024 May 2;70(5):690-692. doi: 10.1093/clinchem/hvad204.

Authors

Dmitri Sviridov^{1

2}, Michael Bukrinsky³

Affiliations

¹ Laboratory of Lipoproteins and Atherosclerosis, Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
² Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia.
³ Department of Microbiology, Immunology and Tropical Medicine, The George Washington University School of Medicine and Health Sciences, Washington, DC, United States.

PMID: 38169349
PMCID: PMC11062762 (available on 2025-01-03)
DOI: 10.1093/clinchem/hvad204

No abstract available

MeSH terms

Anti-HIV Agents / therapeutic use
Cardiovascular Diseases* / drug therapy
HIV Infections* / complications
HIV Infections* / drug therapy
Humans

Substances

Anti-HIV Agents

Grants and funding